United States · FDA National Drug Code directory
Acyclovir
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 82804-005_2ff9056b-ed65-4a2b-abb1-793b1fe9bf4c
- Product NDC
- 82804-005
- Form
- TABLET
- Composition / generic term
- Acyclovir
- Labeler
- Proficient Rx LP
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230620
- Source listing expiry
- 20261231
Source-listed ingredients
- ACYCLOVIR — 400 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 6 TABLET in 1 BOTTLE (82804-005-06) · 82804-005-06
- 15 TABLET in 1 BOTTLE (82804-005-15) · 82804-005-15
- 20 TABLET in 1 BOTTLE (82804-005-20) · 82804-005-20
- 21 TABLET in 1 BOTTLE (82804-005-21) · 82804-005-21
- 30 TABLET in 1 BOTTLE (82804-005-30) · 82804-005-30
- 35 TABLET in 1 BOTTLE (82804-005-35) · 82804-005-35
- 60 TABLET in 1 BOTTLE (82804-005-60) · 82804-005-60
- 90 TABLET in 1 BOTTLE (82804-005-90) · 82804-005-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →